E653 30 Pill - green round, 7mm
Pill with imprint E653 30 is Green, Round and has been identified as Morphine Sulfate Extended-Release 30 mg. It is supplied by Endo Pharmaceuticals Inc.
Morphine is used in the treatment of Chronic Pain; Neonatal Abstinence Syndrome; Pain and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Morphine 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for E653 30
Morphine Sulfate Extended-Release
- Imprint
- E653 30
- Strength
- 30 mg
- Color
- Green
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Endo Pharmaceuticals Inc.
- Inactive Ingredients
-
silicon dioxide,
hypromellose 2910 (15 mPa.s),
lactose monohydrate,
magnesium stearate,
stearic acid,
FD&C Yellow No. 6,
FD&C Blue No. 1
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 60951-0653 (Discontinued) | Endo Pharmaceuticals Inc. |
| 68084-0404 (Discontinued) | Amerisource Health Services |
Related images for "E653 30"
More about morphine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (367)
- Drug images
- Latest FDA alerts (12)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
- Morphine drug information
- Morphine injection
- Morphine (Epidural) (Advanced Reading)
- Morphine Extended-Release Capsules
- Morphine Immediate-Release Tablets and Capsules
Other brands
MS Contin, Roxanol, Duramorph, Kadian, ... +10 more
Professional resources
- Morphine Sulfate monograph
- Morphine ER (FDA)
- Morphine Extended Release Capsules (FDA)
- Morphine Injection (FDA)
- Morphine Oral Solution (FDA)
Other brands
MS Contin, Duramorph, Kadian, Astramorph PF, ... +4 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.